RAPPORT THERAPEUTICS INC (RAPP) Stock Cash Flow
NASDAQ:RAPP - Nasdaq - US75383L1026 - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
| Net Income | -86.97M | -34.79M | -10.65M | |||
| Depreciation Amortization | 676.00K | 112.00K | 15.00K | |||
| Change In Working Capital | -683.00K | 2.65M | 1.49M | |||
| Other non cash items | 14.21M | 4.84M | 5.91M | |||
| OPERATING CASH FLOW | -72.76M | -27.18M | -3.24M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
| Capital Expenditure | -3.75M | -1.64M | -284.00K | |||
| Other Investing Activity | -277.12M | -77.22M | -5.00M | |||
| INVESTING CASH FLOW | -280.87M | -78.86M | -5.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
| Debt Issued/Reduced | N/A | N/A | 8.00M | |||
| Stock Issued/Repurchased | 221.64M | 85.35M | 31.00K | |||
| Other Financing Activity | N/A | 59.79M | 31.65M | |||
| FINANCING CASH FLOW | 306.75M | 145.14M | 39.69M | |||
| CHANGE IN CASH | -46.88M | 39.09M | 31.16M | |||
| FREE CASH FLOW | ||||||
| Operating Cash Flow | -72.76M | -27.18M | -3.24M | |||
| Capital Expenditure | -3.75M | -1.64M | -284.00K | |||
| FREE CASH FLOW | -76.52M | -28.82M | -3.53M | |||
All data in USD